Last reviewed · How we verify

NCT06013553

The Effect of Aerobic Exercise on Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Lymphocyte-Monocyte Ratio in Burn Patients: A Randomized Controlled Study

Status unknown NA Last updated 28 August 2023
What this trial tests

NA trial testing Control Group in Burns in 30 participants. Status unknown.

Timeline
1 August 2023
Primary endpoint
15 October 2023
30 October 2023

Quick facts

Lead sponsorHasan Kalyoncu University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment30
Start date1 August 2023
Primary completion15 October 2023
Estimated completion30 October 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hasan Kalyoncu University

Who can join

Adults 18 to 65, any sex, with Burns or Physiotherapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the study, it was planned to investigate the Effect on Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Lymphocyte-Monocyte Ratio in burn patients by creating 2 different exercise groups. The aim of this study is to investigate the effect of aerobic exercise on neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and lymphocyte-monocyte ratios in burn patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Control Group

Trials testing the same drug.

Other recruiting trials for Burns

Currently open trials in the same condition.

Other Hasan Kalyoncu University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06013553.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing